Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Post from MegRS300 yesterday.
What if ?18 Mar 2024 18:34
I’ve spent the last few days reading the comments with interest and felt it prudent to register and post.
are we at the bottom? no. there’s 2.13% more dilution coming in the next few days as they’ve not landed today. it’s likely a further one is coming in order to obtain funding. are we at the top? no. we are awaiting results which are anticipated as ‘top line’, that in conjunction with secured funding will see a substantial bounce imo..
people talk about funding being ‘difficult’ currently but opportunity attracts money. in over 2 decades they’ve always got funding, even when they were still in the clinic and miles away from anything that could rerate them. do you seriously think after almost 21 years, they’ll not get funding with results pending? as long as i have a hole in my **** i don’t believe that will happen. as a financier you look at 3 things; returns, timescales and risk/reward. all stack up well when you’re putting up the money to legislate against the risk and the depressed price has been due to previous funding arrangements. i’d go as far as to say that it is near on perfect circumstances for them?
other options could include selling up their stake, or elements of, 737? ‘loans’ etc. it’s not a given that a placing will happen. it’s not like sareum is riddled with debt.
cheap take over? (see above about why we are not at the top). under rule 9, if someone gets to 30% they must make an offer for the company that is at least the highest price paid in the proceeding 12 months - 147.50p. 8 times the current share price.
robin hood is clearly puma. it’s normally against forum rules to have multiple logins so i would advocate reporting it to the administrators if you’re that way inclined? they’re clearly a shorter. sadly they don’t have the courage of their convictions so have to try to tell people how they should trade via multiple accounts in order to get their desired outcome. that’s financial coercion and manipulation. it’s market abuse. imagine how they treat people in their private life? puma is here to encourage you to sell to help it’s short, it’s basically said as much.
with regards to the directors, i’m in 2 minds. tm and jr are clearly heavily leveraged here - salary/shares/options/pension etc. more leveraged than any of us. they’ve not issued themselves options for a few years which i feel is interesting. i’d not have begrudged them options based on how far the sp had come - ‘had’ being the operative word.
the directors that have driven us down are the same lot we had when we increased circa 40 fold. do i think they should keep their roles? no. parker has to go. he has finance background but has signed off on consolidation (disaster) and riverfort financing (strong argument for bringing back hanging). without the pandemic we’d not have seen that increase, so they ‘lucked out’. no u
PCS1954 there could well be mileage in you idea.
I would guess that most of us have done multiples of that £1000 in the last few months chasing the dream.
Chase the peelers & the other no hopers down the road and the board start telling the true story.
Baffling that the country is awash with money and we find ourselves in this position.
This post from belhus earlier is on the money me thinks.
I have been very confused for the last few months over the manipulation of the share price since we took the loan
I feel that there is somebody in the backgroud ( I do not think it is Riverfort) that
has kept this share low.
I would not be surprised if an offer for the company came in soon
It would be nice to find out why we were refused the chance to carry out our trials in England
4 Feb 2024 22:11
Not claiming to be a WiP character as we all know how that ended. But I do speak to an individual, and I call them an individual as a VP is one pharma is different to a VP in another. If you know, you know.
The message is that there is huge motivation and pressure to shortening the time to market, how to shorten that timeframe and take compounds from phase 1 to phase 3.
I think we all need to realise the money involved here as we move forward, Tim and John probably (hopefully) realise that. Hence the "noted" phrases they tend to use in recent tyk2 deals and approvals.
If we have good results from phase 1b, somebody tell me why we wouldn't go to a phase 3. As I have it on good information that this is what big pharma are moving towards. Patent expiration should never be overlooked, the ultimate driver for all of this is profit for the company buying the molecule. Competition can and do take a molecular structure from the patent information, add a sugar molecular and then go to market. Speed is everything and to Sareums due, they have been on time with everything since trials started.
Everyone is here to make money but the real money is not the brokers or the traders in London, it's the executives and board of the pharmas, are we on their radar.. with a trial for Psoriasis in competition with a supermajor BMS and now Takeda, don't underestimate the importance of this Phase 1b. Which we will have results for by the end of this year.
Yes, we have been hammered by multiple factors, but the potential is still there and has only got stronger.
Do you believe in the potential or not, we are close, hold the course, buy Sareum or keep buying lottery tickets. I only gamble when I know I'll win and I'm all in.